FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001261213> ?p ?o ?g. }

• W2001261213 endingPage "651" @default.
• W2001261213 startingPage "646" @default.
• W2001261213 abstract "Glatiramer acetate (GA) is a disease-modifying therapy for relapsing-remitting multiple sclerosis (RRMS) with several putative mechanisms of action. Currently, there is paucity ofin vivo human data linking the well-established peripheral immunologic effects of therapy with GA to its potential effects inside the central nervous system (CNS). Brain proton magnetic resonance spectroscopy (MRS) allows in vivo examination of axonal integrity by quantifying the resonance intensity of the neuronal marker N-acetylaspartate (NAA). In a pilot study to investigate the effect of GA on axonal injury, we performed combined brain magnetic resonance imaging (MRI) and MRS studies in 18 treatment naïve RRMS patients initiating therapy with GA at baseline and annually for two years on therapy. A small group of four treatment naïve RRMS patients, electing to remain untreated, served as controls. NAA/Cr was measured in a large central brain volume of interest (VOI) as well as the normal appearing white matter (NAWM) within the VOI. After two years, NAA/Cr in the GA-treated group increased significantly by 10.7% in the VOI (2.179±0.26 versus 1.969±0.24, P=0.03) and by 7.1% in the NAWM (2.239±0.26 versus 2.089±0.31, P=0.04). In the untreated group, NAA/Cr decreased by 8.9% at two years in the VOI (2.019±0.16 versus 1.839±0.21, P=0.03) and 8.2% in the NAWM (2.079±0.24 versus 1.909±0.29, P=0.03). Our data shows that treatment with GA leads to axonal metabolic recovery and protection from sub-lethal axonal injury. These results support an in situ effect of GA therapy inside the CNS and suggest potential neuroprotective effects of GA." @default.
• W2001261213 created "2016-06-24" @default.
• W2001261213 creator A5009994219 @default.
• W2001261213 creator A5014092615 @default.
• W2001261213 creator A5015964287 @default.
• W2001261213 creator A5022889476 @default.
• W2001261213 creator A5048836412 @default.
• W2001261213 creator A5051172260 @default.
• W2001261213 creator A5053878181 @default.
• W2001261213 creator A5063224243 @default.
• W2001261213 creator A5064885043 @default.
• W2001261213 creator A5072656514 @default.
• W2001261213 creator A5081342306 @default.
• W2001261213 date "2005-12-01" @default.
• W2001261213 modified "2023-09-26" @default.
• W2001261213 title "Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis" @default.
• W2001261213 cites W1504018030 @default.
• W2001261213 cites W1963623842 @default.
• W2001261213 cites W1968381353 @default.
• W2001261213 cites W1970573418 @default.
• W2001261213 cites W1976118752 @default.
• W2001261213 cites W1981866033 @default.
• W2001261213 cites W1989217326 @default.
• W2001261213 cites W2005176833 @default.
• W2001261213 cites W2020047554 @default.
• W2001261213 cites W2028862619 @default.
• W2001261213 cites W2029817323 @default.
• W2001261213 cites W2042458479 @default.
• W2001261213 cites W2058027749 @default.
• W2001261213 cites W2061754427 @default.
• W2001261213 cites W2078316783 @default.
• W2001261213 cites W2080121772 @default.
• W2001261213 cites W2084701866 @default.
• W2001261213 cites W2090709719 @default.
• W2001261213 cites W2103970051 @default.
• W2001261213 cites W2105572318 @default.
• W2001261213 cites W2106540089 @default.
• W2001261213 cites W2111468824 @default.
• W2001261213 cites W2127478276 @default.
• W2001261213 cites W2134678910 @default.
• W2001261213 cites W2135142396 @default.
• W2001261213 cites W2135672830 @default.
• W2001261213 cites W2161060662 @default.
• W2001261213 cites W2163113037 @default.
• W2001261213 cites W2169485747 @default.
• W2001261213 cites W2325038063 @default.
• W2001261213 cites W2325735106 @default.
• W2001261213 cites W4244028742 @default.
• W2001261213 cites W4366064463 @default.
• W2001261213 cites W4376522286 @default.
• W2001261213 doi "https://doi.org/10.1191/1352458505ms1234oa" @default.
• W2001261213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16320723" @default.
• W2001261213 hasPublicationYear "2005" @default.
• W2001261213 type Work @default.
• W2001261213 sameAs 2001261213 @default.
• W2001261213 citedByCount "121" @default.
• W2001261213 countsByYear W20012612132012 @default.
• W2001261213 countsByYear W20012612132013 @default.
• W2001261213 countsByYear W20012612132014 @default.
• W2001261213 countsByYear W20012612132015 @default.
• W2001261213 countsByYear W20012612132016 @default.
• W2001261213 countsByYear W20012612132017 @default.
• W2001261213 countsByYear W20012612132018 @default.
• W2001261213 countsByYear W20012612132019 @default.
• W2001261213 countsByYear W20012612132020 @default.
• W2001261213 countsByYear W20012612132021 @default.
• W2001261213 countsByYear W20012612132022 @default.
• W2001261213 crossrefType "journal-article" @default.
• W2001261213 hasAuthorship W2001261213A5009994219 @default.
• W2001261213 hasAuthorship W2001261213A5014092615 @default.
• W2001261213 hasAuthorship W2001261213A5015964287 @default.
• W2001261213 hasAuthorship W2001261213A5022889476 @default.
• W2001261213 hasAuthorship W2001261213A5048836412 @default.
• W2001261213 hasAuthorship W2001261213A5051172260 @default.
• W2001261213 hasAuthorship W2001261213A5053878181 @default.
• W2001261213 hasAuthorship W2001261213A5063224243 @default.
• W2001261213 hasAuthorship W2001261213A5064885043 @default.
• W2001261213 hasAuthorship W2001261213A5072656514 @default.
• W2001261213 hasAuthorship W2001261213A5081342306 @default.
• W2001261213 hasConcept C126322002 @default.
• W2001261213 hasConcept C126838900 @default.
• W2001261213 hasConcept C143409427 @default.
• W2001261213 hasConcept C150903083 @default.
• W2001261213 hasConcept C203014093 @default.
• W2001261213 hasConcept C207001950 @default.
• W2001261213 hasConcept C25498285 @default.
• W2001261213 hasConcept C2778577042 @default.
• W2001261213 hasConcept C2780640218 @default.
• W2001261213 hasConcept C2781192897 @default.
• W2001261213 hasConcept C2989005 @default.
• W2001261213 hasConcept C3020694758 @default.
• W2001261213 hasConcept C529278444 @default.
• W2001261213 hasConcept C71924100 @default.
• W2001261213 hasConcept C86803240 @default.
• W2001261213 hasConceptScore W2001261213C126322002 @default.
• W2001261213 hasConceptScore W2001261213C126838900 @default.
• W2001261213 hasConceptScore W2001261213C143409427 @default.
• W2001261213 hasConceptScore W2001261213C150903083 @default.

• next